drugset / Trial / NCT05844228
A Study to Investigate the Effect of Renal Impairment on the Pharmacokinetics and Safety of VIR-2218
Non-randomizedParallel-groupOpen-labelTreatment
Summary
The rationale of this study is to evaluate the impact of renal function on the PK, safety, and tolerability of VIR-2218 in participants with normal renal function and participants with varying degrees of renal dysfunction who are otherwise medically stable
Timeline
- Start
- 2023-06-01
- Primary completion
- 2025-03-01
- Completion
- 2025-04-21
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | VIR-2218 | Small interfering RNA (siRNA) | — | Subcutaneous |